Canopy Growth (NASDAQ:CGC) operates in the Nasdaq Composite cannabis sector with diversified products including beverages, ...

Over 90 years ago, Hans Selye challenged the notion that stress is inherently negative. He argued that stress is a natural ...

Digital healthcare has reshaped how patients access physicians, manage chronic conditions, and make decisions about their ...

Having insomnia, which includes difficulties falling asleep, staying asleep or waking too early, can lead to daytime dysfunction. When used at night, melatonin can reduce the time it takes to fall ...

Avecho shares today entered trading halt, pending the release of results for the company's synthetic cannabinoid phase III ...

Cannabidiol (CBD) is a naturally occurring compound found in cannabis, thought to have beneficial effects on things like ...

UK-based Ananda Pharma has announced successful completion of its Phase 1 pharmacokinetic study of its MRX1 cannabidiol oral solution to treat chronic pain conditions, with all study objectives met.

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

Ananda Pharma Limited is a UK pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions.

Visitors to Booth 710 will have the opportunity to explore Hometown Hero's growing lineup of hemp-derived drink offerings, ...